Loading...
•
Dec 31, 2020
ICU Medical Q4 2020 Earnings Report
Announced fourth quarter 2020 results.
Key Takeaways
ICU Medical, Inc. reported fourth quarter revenue of $320.5 million, compared to $315.5 million in the same period last year. GAAP net income for the fourth quarter of 2020 was $26.1 million, or $1.21 per diluted share, as compared to GAAP net income of $20.6 million, or $0.96 per diluted share, for the fourth quarter of 2019.
Fourth quarter 2020 revenue was $320.5 million, compared to $315.5 million in the same period last year.
GAAP gross profit for the fourth quarter of 2020 was $119.9 million, as compared to $114.1 million in the same period last year.
GAAP net income for the fourth quarter of 2020 was $26.1 million, or $1.21 per diluted share
Adjusted diluted earnings per share for the fourth quarter of 2020 were $1.77 as compared to $1.94 for the fourth quarter of 2019.
ICU Medical
ICU Medical
ICU Medical Revenue by Segment
Revenue by Segment
Consumables Revenue
CapyFin.comInfusion Systems Revenue
CapyFin.com Forward Guidance
For the Fiscal Year 2021, the Company expects adjusted EBITDA to be in the range of $245 million to $265 million, and adjusted diluted EPS to be in the range of $6.50 to $7.20.
Revenue & Expenses
Visualization of income flow from segment revenue to net income